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Received October 7, 2012; accepted March 12, 2013AbstractRenal hyperparathyroidism usually occurs in chronic renal failure patients on regular dialysis. However, renal hyperparathyroidism resulting
from intrathyroidal parathyroid glands is an uncommon condition. We herein present the case of a 35-year-old woman who has been on he-
modialysis for 20 years. She had renal hyperparathyroidism with generalized weakness and bone pain for 2 years. The patient initially underwent
parathyroidectomy at a local institution, during which two large parathyroid glands were resected from the right side (no parathyroid glands were
found on the left side); however, the surgical procedure was unsuccessful, and the patient had persistent renal hyperparathyroidism after the
operation. She was then transferred to our hospital and ectopic intrathyroidal parathyroid glands were localized by neck ultrasonography and
technetium-99m sestamibi scans with single-photon emission computed tomography imaging preoperatively. A left thyroid lobectomy was
performed and two intrathyroidal parathyroid glands were found. The patient recovered uneventfully and her symptoms resolved. Therefore,
clinicians should be aware of the possibility of renal hyperparathyroidism resulting from intrathyroidal parathyroid glands in cases where the
renal hyperparathyroidism persists after parathyroidectomy.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Renal hyperparathyroidism occurs in patients with chronic
renal failure. Approximately 15% of patients after 10 years
and 38% of patients after 20 years of dialysis become re-
fractory to medical treatment and therefore require para-
thyroidectomy.1,2 Persistent or recurrent renal
hyperparathyroidism occurs in patients with ectopic or su-
pernumerary parathyroid glands that are missed on initial
parathyroidectomy. However, renal hyperparathyroidism
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with persistent renal hyperparathyroidism resulting from
intrathyroidal parathyroid glands. Good localization of intra-
thyroidal parathyroid glands is considered crucial preopera-
tively. Technetium-99 m (Tc-99m) sestamibi scans with
single-photon emission computed tomography (SPECT) im-
aging and ultrasonography are useful techniques for accurate
localization of intrathyroidal parathyroid glands.4 A thyroid
lobectomy should be considered in situations where an intra-
thyroidal parathyroid gland is suspected to resolve persistent
renal hyperparathyroidism.
2. Case report
A 35-year-old uremic woman has been on hemodialysis for
20 years. Her kidney transplantation failed when she was 28
years old. She had renal hyperparathyroidism with weakness,ociation. All rights reserved.
Fig. 1. Two heterogeneous hypoechoic lesions in the (A) upper
(1.53 cm  1.0 cm, white arrow) and (B) lower (0.90 cm  0.94 cm, white
arrow) poles of the left lobe thyroid gland.
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years. The initial intact parathyroid hormone (iPTH) level was
930 pg/mL and her thyroid function test measurements were
as follows: T3, 64.56 ng/dL (range, 86e187 ng/dL); thyroid-
stimulating hormone, 10 IU/mL (range, 0.25e5.0 IU/mL);
and free T4, 0.72 ng/dL (range, 0.8e2.0 ng/dL). She under-
went a prior unsuccessful parathyroidectomy at a local insti-
tution, during which two large parathyroid glands were
resected from the right side (no parathyroid glands were found
on the left side). Two weeks after the initial operation, her
iPTH level was 500 pg/mL and her symptoms persisted.
Subsequently, her serum iPTH level continued to increase andFig. 2. Increased methoxyisobutylisonitrilewas 3411 pg/mL with concurrently elevated serum calcium
level (Ca2þ, 12.1 mg/dL).
She was transferred to our hospital and neck sonography
was performed, which showed a 1.5 cm  1 cm  1 cm
hypoechoic nodule in the left upper pole of the thyroid and a
1 cm  1 cm  1 cm heterogeneous nodule in the left lower
pole of the thyroid without other lesions consistent with
parathyroid tumors (Fig. 1). The Tc-99m sestamibi scan with
SPECT showed increased methoxyisobutylisonitrile (MIBI)
uptake in the left thyroid bed in both early and delayed im-
aging phases, with a stronger uptake at the left upper pole of
the thyroid (Fig. 2). Because of concordant MIBI and ultra-
sound findings, we suspected persistent renal hyperparathy-
roidism resulting from the left intrathyroidal parathyroid
glands.
During the operation, we explored the left side of the neck,
and found no parathyroid tumors. We then performed a left
thyroid lobectomy based on the results of preoperative local-
ization studies. We found two tumors in the left lobe of the
thyroid (upper: 1.5 cm  1.0 cm  1.0 cm and lower:
1.0 cm  1.0 cm  0.8 cm). Frozen biopsy confirmed the
excised mass to be parathyroid tissue (Fig. 3). Permanent
pathological examination was performed, and the results
showed intrathyroidal parathyroid glands with nodular hy-
perplasia. Postoperative serum iPTH level was 10.3 pg/mL and
calcium was 9.2 mg/dL. Her symptoms resolved following the
surgical procedure.
3. Discussion
Persistent and recurrent hyperparathyroidism are expected
outcomes of subtotal parathyroid resection; however, its rate
depends on the extent of initial resection and the duration of
follow up. Remnant parathyroid tissue will grow, irrespective
of whether it was left on purpose (as in a planned three-and-a-
half gland subtotal parathyroidectomy) or could not be found
during the initial operation (as in our patient). The reported
rates of persistent and recurrent hyperparathyroidism are
10e12% for both subtotal parathyroidectomy and total para-
thyroidectomy with autotransplantation, and 0e4% for total
parathyroidectomy without autotransplantation.5 Causes for(MIBI) uptake in the left thyroid bed.
Fig. 3. Two intrathyroid tumors in the left lobe of the thyroid.
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renal hyperparathyroidism undergoing parathyroidectomy are
ectopic gland, supernumerary gland, and parathyromatosis.6e8
Persistent renal hyperparathyroidism is usually defined as a
condition of elevated serum iPTH level (>300 pg/mL) within
6 months postoperatively.9
The intrathyroidal parathyroid glands are usually found
incidentally after thyroidectomy with a reported rate of
1.4e3.2%.3 There is a continuing debate about the embryo-
logic origin of intrathyroid parathyroid glands. Most believe
that they are embryologically inferior parathyroid glands.10 In
a previous study of 43 patients with intrathyroidal parathyroid
glands, Proye et al10 reported three superior and 44 inferior
glands.11 Our patient with simultaneously superior and inferior
intrathyroidal parathyroid glands is distinctively unusual.
Other more common locations for ectopic superior parathyroid
glands are the retroesophagealeretropharyngeal area and the
posterior mediastinum.
Ultrasonography is a convenient, noninvasive, and inex-
pensive tool for preoperative localization. Although thyroid
nodules in patients with renal hyperparathyroidism are very
common,12 a thyroid nodule detected by ultrasonography
during an examination for patients with parathyroid disease
could be an intrathyroidal parathyroid gland. When in doubt,
fine-needle aspiration biopsy (FNAB) with cytology and iPTH
assay should be performed, which can easily distinguish a
thyroid nodule from an intrathyroidal parathyroid.13 Ultraso-
nography is a very useful preoperative localization study for
hyperparathyroidism; it is also the most useful for the study of
intrathyroidal parathyroid glands.11,14 However, it is indeed
difficult to detect intrathyroidal parathyroid glands when the
thyroid nodule is not big enough to be eligible for performing
further studies (e.g., sono-guided FNAB) based on the criteria
suggested by the American Thyroid Association Guidelines
and National Comprehensive Cancer Network Guidelines.15,16
The Tc-99m sestamibi scan is also a useful modality for
preoperative localization. It is, however, less sensitive for renal
hyperparathyroidism (76.2% for nodular type and 28.6% for
diffuse type) than for primary hyperparathyroidism (88.4% for
solitary adenoma and 44.46% for multiple adenoma).17,18 Thesensitivity of the scan results can be increased by combining it
with ultrasonography if the two studies are concordant.9 Other
studies such as computed tomography/magnetic resonance
imaging or selective venous sampling can also be used in
patients with persistent/recurrent renal hyperparathyroid-
ism.4,19,20 However, these studies are invasive and expensive,
and are used only for difficult cases.
For recurrent or persistent uremic hyperparathyroidism, the
usual methods of treatments are medical therapy, reoperation,
and percutaneous ethanol, calcitriol, and maxacalcitol injec-
tion therapies.9,21 Thyroidectomy is not part of routine para-
thyroidectomy, whether for primary or for renal
hyperparathyroidism. However, thyroid lobectomy should be
considered in situations where an intrathyroidal parathyroid
gland is suspected perioperatively. Before ultrasound became a
routine preoperative examination, a “blind thyroid lobectomy”
was usually performed when the surgeon is exhausted in the
search for a missing parathyroid gland on the same side (after
doing a cervical thymectomy, explored the tracheoesophageal
groove, and opened the carotid sheath).22 At present, with
ultrasound being a routine preoperative examination, the sur-
geon may consider performing a thyroid lobectomy earlier
when a missing parathyroid gland is on the same side in which
there is a hypoechoic “thyroid nodule”, which has not had
been confirmed to be a colloid nodule by a prior FNAB. An
enucleation of the intrathyroidal parathyroid, as an enucleation
of a thyroid nodule, is a poor treatment with potential prob-
lems of rupture and complications associated with possible
need for reoperation.
Our patient had uncertain ultrasonography examination
over the usual location and ectopic sites of parathyroid glands.
Although Tc-99m sestamibi scans can help to confirm the
ultrasound findings, occasional follicular thyroid tumors can
cause false positives.23 If an ultrasound-guided FNAB is
considered, the aspirate should be sent for both cytological
analysis and iPTH assay. In general, measuring iPTH in the
aspirate is more accurate than performing a cytological ex-
amination.13 However, one should be aware of the possibility
of needle-track seeding causing iatrogenic parathyroidosis.
Intrathyroidal parathyroid glands can be missed during the
initial operation, which could subsequently result in persistent/
recurrent diseases. This rare anatomic anomaly should be
considered when a parathyroid gland is not identified but a
thyroid nodule was present on preoperative ultrasound. For re-
operations, preoperative localization studies including ultra-
sonography and Tc-99m sestamibi scans are crucial. Thyroid
lobectomy should be considered during the initial operation or
re-operation when intrathyroidal parathyroid is suspected.
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